Recombinant Human PSMB1 Protein ，GST

PSMB1, or Proteasome Subunit Beta Type-1, is a critical component of the 26S proteasome, which plays a pivotal role in the degradation of ubiquitinated proteins, thereby regulating various cellular processes including cell cycle progression, signal transduction, and the response to oxidative stress. Research into PSMB1 has gained momentum due to its involvement in the immune response and its potential implications in various diseases, including cancer and neurodegenerative disorders. Mutations or dysregulation of PSMB1 can lead to impaired proteasome activity, resulting in the accumulation of damaged proteins and contributing to pathologies. Recombinant PSMB1 proteins have been studied to better understand their structure-function relationship and to develop therapeutic strategies aimed at modulating proteasome function. Additionally, PSMB1 is of interest in the field of biomarker discovery, as its expression levels can indicate disease states or responses to therapy. The study of PSMB1 is therefore not only integral to understanding fundamental cellular processes but also holds promise for the development of new diagnostic and therapeutic approaches in precision medicine. Advances in recombinant DNA technology have facilitated the production and characterization of PSMB1, enabling researchers to explore its potential in drug discovery and the design of proteasome inhibitors with selective activity.